ROCKVILLE, Md. (MedPage Today) -- Long-acting beta agonists are associated with an increased risk of disease-related death and hospitalization compared with other medications used to treat the condition, according to an FDA meta-analysis.
FDA Documents Say Drugs Increase Risk of Asthma-Related DeathCourtesy MedPage Today Allergy & Immunology Fri, 12/05/2008 - 15:45
ROCKVILLE, Md. (MedPage Today) -- Long-acting beta agonists are associated with an increased risk of disease-related death and hospitalization compared with other medications used to treat the condition, according to an FDA meta-analysis. More related itemsKids at Increased Risk with Long-Acting Beta-Agonists...
Asthma Hospitalization Among Children Holds Steady
Combined asthma medication therapy shown to reduce...
|
Popular by tags WeekMonth |
Post new comment